Similar articles

• Dapsone in the treatment of cutaneous leishmaniasis.

  Dogra J, Lal BB, Misra SN. Dogra J, et al. Int J Dermatol. 1986 Jul-Aug;25(6):398-400. doi: 10.1111/j.1365-4362.1986.tb03435.x. Int J Dermatol. 1986. PMID: 3531044 Clinical Trial.
• A double-blind study on the efficacy of oral dapsone in cutaneous leishmaniasis.

  Dogra J. Dogra J. Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):212-3. doi: 10.1016/0035-9203(91)90025-t. Trans R Soc Trop Med Hyg. 1991. PMID: 1887473 Clinical Trial.
• Ultrastructure study of experimental cutaneous leishmaniasis before and after Dapsone intake.

  Eissa MM, Younis LK, Badawy EA. Eissa MM, et al. J Egypt Soc Parasitol. 1997 Aug;27(2):539-52. J Egypt Soc Parasitol. 1997. PMID: 9257993
• Therapeutic options for cutaneous leishmaniasis.

  Mahajan VK, Sharma NL. Mahajan VK, et al. J Dermatolog Treat. 2007;18(2):97-104. doi: 10.1080/09546630601159474. J Dermatolog Treat. 2007. PMID: 17520466 Review.
• Cutaneous leishmaniasis in Texas: report of a case and review of the literature.

  Furner BB. Furner BB. J Am Acad Dermatol. 1990 Aug;23(2 Pt 2):368-71. J Am Acad Dermatol. 1990. PMID: 2203832 Review.